G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCT.

Micallef, I N; Jacobsen, E D; Shaughnessy, P; Gandhi, P J; Calandra, G; van Rhee, F; Uberti, J

Micallef, I N; Jacobsen, E D; Shaughnessy, P; Gandhi, P J; Calandra, G; van Rhee, F; Uberti, J.

Bone Marrow Transplant ; 48(2): 303-4, 2013 Feb.

Article in En | MEDLINE | ID: mdl-22773123

Subject(s)

Granulocyte Colony-Stimulating Factor/therapeutic use; Hematopoietic Stem Cell Mobilization/methods; Heterocyclic Compounds/therapeutic use; Leukopenia/blood; Thrombocytopenia/blood; Benzylamines; Blood Component Removal/methods; Cyclams; Hematopoietic Stem Cell Transplantation; Humans; Leukocyte Count; Leukopenia/pathology; Lymphoma, Non-Hodgkin/blood; Lymphoma, Non-Hodgkin/surgery; Multiple Myeloma/blood; Multiple Myeloma/surgery; Platelet Count; Retrospective Studies; Thrombocytopenia/pathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Granulocyte Colony-Stimulating Factor / Hematopoietic Stem Cell Mobilization / Heterocyclic Compounds / Leukopenia Type of study: Observational_studies Limits: Humans Language: En Journal: Bone Marrow Transplant Year: 2013 Document type: Article

Fulltext

XML

PubMed Links

Search on Google